Trials / Completed
CompletedNCT05045989
Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot
Mixed-methods Process Evaluation of a Residence-Based SARS-CoV-2 Testing Participation Pilot on a UK University Campus During the COVID-19 Pandemic.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (actual)
- Sponsor
- University of Nottingham · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Mixed-methods process evaluation of a residence-based asymptomatic SARS-CoV-2 testing participation pilot
Detailed description
Regular testing for SARS Coronavirus 2 (SARS-CoV-2) is an important strategy for controlling virus outbreaks on university campuses during the COVID-19 pandemic but testing participation rates can be low. The Residence-Based Testing Participation Pilot (RB-TPP) was a novel intervention implemented at two student residences on a large university campus in the UK over four weeks. The aim of the pilot was to increase the frequency of asymptomatic SARS-CoV-2 saliva testing onsite. This process evaluation aimed to determine whether RB-TPP was implemented as planned and identify implementation barriers and facilitators. A mixed-methods process evaluation was conducted alongside the RB-TPP. Evaluation participants were students (who opted in, or out of the RB-TPP) and staff with a role in service provision or student support. Monitoring data were collected from the intervention delivery team and meeting records. Data were collected from students via an online survey (n=152) and seven focus groups (n=30), and from staff via individual interviews (n=13). Quantitative data were analysed descriptively and qualitative data thematically.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Residence-based testing participation pilot (SARS-CoV-2 testing with relaxed social distancing restrictions) | SARS-CoV-2 asymptomatic saliva testing (as available to all students at staff at the participating university) delivered with relaxed social distancing (behavioural element) in two halls of residence. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2021-09-16
- Last updated
- 2021-09-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05045989. Inclusion in this directory is not an endorsement.